Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatima Amanat

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Mbio|July 27, 2021
Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect <i>In Vivo</i> in a Mouse Model in a Neutralization-Dependent MannerFatima Amanat, Shirin Strohmeier, Wen-Hsin Lee, et al.
Journal of Virology|March 31, 2017
Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse ModelMegan E Ermler, Ericka Kirkpatrick, Weina Sun, et al.
Iscience|November 2, 2020
Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human MilkAlisa Fox, Jessica Marino, Fatima Amanat, et al.
Journal of Virology|October 30, 2015
Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in MiceTeddy John Wohlbold, Veronika Chromikova, Gene S Tan, et al.
Plos One|April 5, 2018
An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparationsMadhusudan Rajendran, Weina Sun, Phillip Comella, et al.
Plos One|March 9, 2022
The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over timeAlisa Fox, Jessica Marino, Fatima Amanat, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2020
Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 InfectionRaveen Rathnasinghe, Shirin Strohmeier, Fatima Amanat, et al.
Journal of Virology|January 11, 2019
Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in MiceGuha Asthagiri Arunkumar, Andriani Ioannou, Teddy John Wohlbold, et al.
Emerging Microbes & Infections|October 19, 2020
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infectionRaveen Rathnasinghe, Shirin Strohmeier, Fatima Amanat, et al.
Mbio|March 23, 2017
Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic SinMadhusudan Rajendran, Raffael Nachbagauer, Megan E Ermler, et al.
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Mbio|July 27, 2021
Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect <i>In Vivo</i> in a Mouse Model in a Neutralization-Dependent MannerFatima Amanat, Shirin Strohmeier, Wen-Hsin Lee, et al.
Journal of Virology|March 31, 2017
Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse ModelMegan E Ermler, Ericka Kirkpatrick, Weina Sun, et al.
Iscience|November 2, 2020
Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human MilkAlisa Fox, Jessica Marino, Fatima Amanat, et al.
Journal of Virology|October 30, 2015
Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in MiceTeddy John Wohlbold, Veronika Chromikova, Gene S Tan, et al.
Plos One|April 5, 2018
An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparationsMadhusudan Rajendran, Weina Sun, Phillip Comella, et al.
Plos One|March 9, 2022
The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over timeAlisa Fox, Jessica Marino, Fatima Amanat, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2020
Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 InfectionRaveen Rathnasinghe, Shirin Strohmeier, Fatima Amanat, et al.
Journal of Virology|January 11, 2019
Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in MiceGuha Asthagiri Arunkumar, Andriani Ioannou, Teddy John Wohlbold, et al.
Emerging Microbes & Infections|October 19, 2020
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infectionRaveen Rathnasinghe, Shirin Strohmeier, Fatima Amanat, et al.
Mbio|March 23, 2017
Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic SinMadhusudan Rajendran, Raffael Nachbagauer, Megan E Ermler, et al.
Pageof 12